FDA lawyer digs in her heels as Makena accelerated approval withdrawal saga drags on

It’s been almost 18 months since the FDA recommended that Covis Pharma withdraw its controversial preterm birth drug Makena, and still the drug, which first won an accelerated approval in 2011 but failed a confirmatory trial in 2018, remains on the market.